Workflow
百元股
icon
Search documents
品茗科技跌2.02%,成交额9345.94万元,主力资金净流出785.25万元
Xin Lang Cai Jing· 2025-11-20 03:15
Core Viewpoint - The stock of Pinming Technology has experienced significant fluctuations, with a year-to-date increase of 487.44%, but a recent decline of 2.02% on November 20, indicating potential volatility in investor sentiment [1][2]. Financial Performance - For the period from January to September 2025, Pinming Technology achieved a revenue of 288 million yuan, representing a year-on-year growth of 3.76%, while the net profit attributable to shareholders was 48.43 million yuan, showing a substantial increase of 267.42% [2]. - The company has distributed a total of 152 million yuan in dividends since its A-share listing, with 75.99 million yuan distributed over the past three years [3]. Stock Market Activity - As of November 20, the stock price was 140.04 yuan per share, with a market capitalization of 11.041 billion yuan. The trading volume was 93.45 million yuan, with a turnover rate of 0.83% [1]. - The stock has appeared on the "Dragon and Tiger List" six times this year, with the most recent appearance on October 15, where it recorded a net purchase of 23.38 million yuan [1]. Shareholder Information - As of September 30, the number of shareholders increased to 6,564, a rise of 39.30%, while the average circulating shares per person decreased by 28.21% to 12,011 shares [2]. Business Overview - Pinming Technology, established on July 11, 2011, focuses on "digital construction" technologies and products, providing solutions from the construction preparation phase to project completion, addressing various needs in cost, safety, quality, and information management [2]. - The company's revenue composition includes 57.44% from information software products and 42.56% from smart construction site products [2].
深沪北百元股数量达150只,电子行业占比最高
Core Insights - The average stock price of A-shares is 13.75 yuan, with 150 stocks priced over 100 yuan, indicating market interest in high-priced stocks [1] - The Shanghai Composite Index closed at 3946.74 points, up 0.18%, while stocks over 100 yuan averaged a decline of 0.56%, underperforming the index by 0.74 percentage points [1] - In the past month, stocks priced over 100 yuan have seen an average increase of 5.91%, outperforming the Shanghai Composite Index's 2.79% increase [2] Stock Performance - The highest closing price among stocks over 100 yuan is Kweichow Moutai at 1471.01 yuan, down 0.34% [1] - Other notable high-priced stocks include Cambricon Technologies at 1332.00 yuan and Yuanjie Technology at 573.43 yuan [1] - Among the 150 stocks over 100 yuan, 44 stocks increased in price today, with the largest gainers being LianTe Technology and Spring Power [1] Industry Distribution - The electronics sector has the highest representation among stocks over 100 yuan, with 56 stocks, accounting for 37.33% of the total [2] - Other significant sectors include computer and power equipment, with 18 and 15 stocks respectively [2] - The majority of high-priced stocks are listed on the ChiNext board, with 49 stocks, while the main board has 31 stocks [2] Institutional Ratings - Four stocks priced over 100 yuan received "buy" ratings from institutions today, including Yuanjie Technology and Mindray Medical [2]
联影医疗跌2.00%,成交额2.42亿元,主力资金净流出1420.74万元
Xin Lang Cai Jing· 2025-11-19 06:07
Core Viewpoint - The stock of United Imaging Healthcare has experienced fluctuations, with a recent decline of 2.00% and a total market capitalization of 108.43 billion yuan, reflecting a mixed performance in the stock market [1]. Financial Performance - For the period from January to September 2025, United Imaging Healthcare reported a revenue of 8.859 billion yuan, representing a year-on-year growth of 27.39%, and a net profit attributable to shareholders of 1.120 billion yuan, which is a 66.91% increase compared to the previous year [2]. - The company has distributed a total of 641 million yuan in dividends since its A-share listing [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for United Imaging Healthcare increased to 32,400, marking a 96.28% rise from the previous period, while the average number of circulating shares per person decreased by 29.23% to 25,444 shares [2]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 19.036 million shares, a decrease of 2.9809 million shares from the previous period [3].
深沪北百元股数量达149只,电子行业占比最高
市场表现方面,收盘股价超百元股中,今日平均下跌0.26%,跑赢沪指0.56个百分点。今日上涨的有67 只,涨幅居前的有东芯股份、天普股份等,下跌的有82只,跌幅居前的有华盛锂电、北方长龙等。 追溯发现,最新百元股近一个月平均上涨6.46%,其间沪指上涨2.61%,涨幅居前的有华盛锂电、线上 线下、鼎泰高科等,涨幅分别为161.09%、87.39%、62.59%,今年以来平均涨幅为113.71%,强于沪指 96.17%,累计涨幅居前的有上纬新材、天普股份、胜宏科技等,涨幅分别为1545.60%、811.34%、 567.70%。 以最新收盘价计算,A股平均股价为13.76元,其中股价超过100元的有149只。 百元股作为判定市场热度的信号之一,历来受到投资者关注。证券时报·数据宝统计显示,截至11月18 日收盘,沪指报收3939.81点,下跌0.81%,A股平均股价为13.76元,个股股价分布看,股价超过100元 的有149只,股价在50元至100元的有441只,股价在30元至50元的有782只。 股价超百元个股中,收盘价最高的是贵州茅台,今日报收1476.00元,上涨0.34%,其次是寒武纪、源杰 科技等,最 ...
影石创新跌2.10%,成交额1.68亿元,主力资金净流出1546.33万元
Xin Lang Zheng Quan· 2025-11-18 05:33
Core Viewpoint - The stock of YingShi Innovation has experienced fluctuations, with a year-to-date increase of 47.53%, but recent declines in the short term raise concerns about its market performance [1][2]. Group 1: Stock Performance - On November 18, YingShi Innovation's stock fell by 2.10%, trading at 261.12 CNY per share, with a total transaction volume of 1.68 billion CNY and a market capitalization of 104.709 billion CNY [1]. - Year-to-date, the stock has risen by 47.53%, but it has seen a decline of 1.72% over the last five trading days, 5.82% over the last 20 days, and 3.04% over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, YingShi Innovation reported a revenue of 6.611 billion CNY, representing a year-on-year growth of 67.18%, while the net profit attributable to shareholders was 792 million CNY, a decrease of 5.95% year-on-year [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for YingShi Innovation increased by 36.16% to 23,100, with an average of 1,318 circulating shares per shareholder, down by 26.56% [2]. - New institutional shareholders include Bosera Science and Technology Innovation Mixed Fund, holding 262,600 shares, and other funds such as Fortune Consumer Theme Mixed Fund and Fortune Value Creation Mixed Fund, which are also new entrants among the top ten circulating shareholders [3].
百元股数量达151只 一日减少3只
以最新收盘价计算,A股平均股价为13.89元,其中股价超过100元的有151只,相比上一个交易日减少3 只。 百元股作为判定市场热度的信号之一,历来受到投资者关注。证券时报·数据宝统计显示,截至11月17 日收盘,沪指报收3972.03点,下跌0.46%,A股平均股价为13.89元,个股股价分布看,股价超过100元 的有151只,股价在50元至100元的有452只,股价在30元至50元的有783只。 股价超百元个股中,收盘价最高的是贵州茅台,今日报收1471.00元,上涨0.99%,其次是寒武纪、源杰 科技等,最新收盘价分别为1303.10元、527.01元。 市场表现方面,收盘股价超百元股中,今日平均上涨0.42%,跑赢沪指0.88个百分点。今日上涨的有71 只,涨幅居前的有腾景科技、北方长龙等,下跌的有80只,跌幅居前的有骄成超声、迈为股份等。 追溯发现,最新百元股近一个月平均上涨4.78%,其间沪指上涨1.43%,涨幅居前的有华盛锂电、线上 线下、石大胜华等,涨幅分别为218.01%、90.54%、86.44%,今年以来平均涨幅为115.32%,强于沪指 96.81%,累计涨幅居前的有上纬新材、天普股份 ...
百元股数量达151只,一日减少3只
(原标题:百元股数量达151只,一日减少3只) 以最新收盘价计算,A股平均股价为13.89元,其中股价超过100元的有151只,相比上一个交易日减少3只。 百元股作为判定市场热度的信号之一,历来受到投资者关注。证券时报•数据宝统计显示,截至11月17日收盘,沪指报收3972.03点,下跌0.46%, A股平均股价为13.89元,个股股价分布看,股价超过100元的有151只,股价在50元至100元的有452只,股价在30元至50元的有783只。 股价超百元个股中,收盘价最高的是贵州茅台,今日报收1471.00元,上涨0.99%,其次是寒武纪、源杰科技等,最新收盘价分别为1303.10元、 527.01元。 市场表现方面,收盘股价超百元股中,今日平均上涨0.42%,跑赢沪指0.88个百分点。今日上涨的有71只,涨幅居前的有腾景科技、北方长龙等, 下跌的有80只,跌幅居前的有骄成超声、迈为股份等。 追溯发现,最新百元股近一个月平均上涨4.78%,其间沪指上涨1.43%,涨幅居前的有华盛锂电、线上线下、石大胜华等,涨幅分别为218.01%、 90.54%、86.44%,今年以来平均涨幅为115.32%,强于沪指96. ...
联影医疗跌2.02%,成交额4.06亿元,主力资金净流出5849.26万元
Xin Lang Cai Jing· 2025-11-17 05:53
Core Viewpoint - The stock of United Imaging Healthcare has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 6.28%, indicating volatility in market performance [1]. Financial Performance - For the period from January to September 2025, United Imaging Healthcare reported a revenue of 8.859 billion yuan, representing a year-on-year growth of 27.39% [2]. - The net profit attributable to shareholders for the same period was 1.120 billion yuan, showing a significant increase of 66.91% compared to the previous year [2]. Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for United Imaging Healthcare reached 32,400, an increase of 96.28% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 29.23% to 25,444 shares [2]. - The stock's trading activity showed a net outflow of 58.49 million yuan from main funds, with significant selling pressure observed [1]. Company Overview - United Imaging Healthcare, established on March 21, 2011, and listed on August 22, 2022, specializes in high-performance medical imaging equipment, radiation therapy products, and medical digital solutions [1]. - The company's revenue composition includes 81.29% from medical imaging diagnostic equipment and radiation therapy equipment sales, 13.56% from maintenance services, and 4.68% from other sources [1]. Institutional Holdings - As of September 30, 2025, major institutional shareholders include Hong Kong Central Clearing Limited and various ETFs, with notable reductions in their holdings [3].
春风动力跌2.03%,成交额1.62亿元,主力资金净流入858.50万元
Xin Lang Zheng Quan· 2025-11-17 02:35
Core Points - The stock price of Chuangfeng Power dropped by 2.03% on November 17, trading at 237.45 CNY per share with a market capitalization of 36.23 billion CNY [1] - Year-to-date, Chuangfeng Power's stock has increased by 54.97%, but it has seen a decline of 3.16% in the last five trading days and 16.96% over the past 60 days [1] - For the period from January to September 2025, Chuangfeng Power reported a revenue of 14.896 billion CNY, reflecting a year-on-year growth of 30.10%, and a net profit of 1.415 billion CNY, up 30.89% year-on-year [2] Company Overview - Chuangfeng Power, established on December 9, 2003, and listed on August 18, 2017, is located in Hangzhou, Zhejiang Province. The company specializes in the research, production, and sales of all-terrain vehicles, motorcycles, yachts, and recreational sports equipment [1] - The revenue composition of Chuangfeng Power includes 47.95% from four-wheeled vehicles, 42.79% from two-wheeled vehicles, 6.89% from parts and others, and 2.38% from other supplementary products [1] Shareholder Information - As of September 30, 2025, the number of shareholders for Chuangfeng Power increased by 31.21% to 13,300, with an average of 11,503 shares per shareholder, a decrease of 23.79% [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited as the third-largest shareholder with 7.6681 million shares, and the Southern CSI 500 ETF as a new entrant in the tenth position with 1.5611 million shares [3]
深沪北百元股数量达159只,电子行业占比最高
Core Insights - The average stock price of A-shares is 14.08 yuan, with 159 stocks priced over 100 yuan, indicating market enthusiasm [1] - The Shanghai Composite Index closed at 4029.50 points, up 0.73%, while stocks over 100 yuan averaged a 1.66% increase, outperforming the index by 0.93 percentage points [1][2] - The top-performing high-priced stocks include Guizhou Moutai at 1470.38 yuan, with a 0.36% increase, and others like Cambricon and Yuanjie Technology [1][2] Market Performance - The average increase of stocks priced over 100 yuan in the past month is 3.96%, compared to a 3.40% increase in the Shanghai Composite Index [2] - Notable high-performing stocks include Huasheng Lithium Battery, Shangwei New Materials, and Xiangnan Chip Creation, with increases of 153.49%, 91.07%, and 81.22% respectively [2] - Year-to-date, the average increase for high-priced stocks is 112.08%, surpassing the Shanghai Composite Index's 91.86% [2] Industry Distribution - The high-priced stocks are concentrated in the electronics, computer, and power equipment sectors, with electronics comprising 35.85% of the total [2] - The breakdown of high-priced stocks by sector includes 57 from electronics, 20 from computers, and 18 from power equipment [2] Institutional Ratings - Seven high-priced stocks received "buy" ratings from institutions, including Sails, Mindray Medical, and Jinbo Biological [2]